Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Mr. Dominique J. Filloux

Chief Operating Officer

Ms. Kaile  Zagger

Chief Commercial Officer

Dr. Evgueni V. Skalnyi M.D.

Chief Medical Officer

Ms. Wendy  Bowman

Vice President of Human Resources

Ms. Joanne  Long

Vice President of Corporate Controller

Mr. Todd  Usen

President, Chief Executive Officer & Director

Mr. Joel R. Jung MBA

Chief Financial Officer

Име	Пазарна капитализация
R1 RCM Inc.	0M
ETAO International Co., Ltd.	0M
Sharecare, Inc.	0M
Pangenomic Health Inc.	0M
National Research Corporation	0M
TOWA Hi SYSTEM CO.,LTD.	0M
MTI Ltd.	0M
Kanamic Network Co.,LTD	0M
Longmaster Information & Technology Co., Ltd.	0M
Cognetivity Neurosciences Ltd.	0M

Minerva Surgical, Inc.

Minerva Surgical, Inc. Списък на конкурентите

Основни конкуренти